Local Support

We are a global leader in the field of rapid diagnostic tests designed to improve the quality of patient care. Specific product lines include tests for rapid and early diagnosis in the fields of cardiovascular, infectious diseases, women's health, drugs of abuse and oncology.

Viewpoints

Point-of-care diagnostics is a growing and dynamic industry helping to improve clinical and economic outcomes globally. Discover a variety of expert viewpoints on new innovations, insights, and impacts that are shaping the future of diagnostics around the world.

Products & Services

Cardiometabolic

Our products and services include tests to assist in the diagnosis and management of many cardiometabolic factors and conditions including cardiac markers, glucose and HbA1C, cholesterol levels, blood gases, and home monitoring for VAD and oral anticoagulation.

Toxicology Products & Services

Alere™ Toxicology offers drug testing products and services that are used in a multitude of settings such as hospitals, clinics, physician offices, criminal justice, workplace, rehabilitation, occupational health clinics, and home testing.

IQCP Support Resources

The Clinical Laboratory Improvement Amendments (CLIA) program recently introduced the Individualized Quality Control Plan (IQCP) as a new quality control option for nonwaived testing. We are pleased to provide you with materials to support your IQCPs.

Strep A pharyngitis

Group A Streptococcus is the most significant pathogen causing pharyngitis. Accurate diagnosis of the etiological agent is necessary to properly treat the disease. In the case of Group A Streptococcus, antibiotic therapy is the treatment of choice. If left untreated, serious sequelae such as rheumatic fever may occur.

Streptococcus pyogenes, also known as group A Streptococcus, contributes to 20 percent of infections of tonsillitis, pharyngitis, and scarlet fever and causes impetigo (pyoderma)1. It typically occurs in young children, and prevalence is high in schools, nursing homes, and hospitals4,5. Early diagnosis and treatment have been shown to reduce the severity of symptoms and to reduce further complications2. Left untreated, complications such as acute rheumatic fever, toxic shock-like syndrome and glomerulonephritis, may occur3.

Slowing antibiotic resistance through rapid diagnostics

As microbes become more resilient to antibiotics, common diseases and infections are becoming harder to treat. Before long, operations like organ transplants and C-sections could be too risky to perform. What does that mean to the future of medicine?